Gülbengü Yüksel

Gülbengü Kuzgun Yüksel is Head of Quality of Tigen, a Swiss clinical-stage biotech in the field of T cell therapies to cure cancer. With a background in cell & gene therapy, biologics and small molecules manufacturing and quality procedures, she has more than 24 years of experience as an operations and quality professional. Committed to creating streamlined processes that consider patient needs, organisational efficiency, and emerging technological advancements, she is driven by challenging the status quo and improving the way things are done. Prior to joining Tigen Pharma, she was instrumental in constructing state-of-the-art manufacturing facilities and developing thriving businesses across various organisations and geographies, such as Turkey, Austria, Switzerland. Her experience also includes managing cross-functional teams, implementing innovative strategies, and effectively collaborating with international health authorities to ensure compliance with global regulations.